Cell Signaling Technology

G-beta-L (86B8) Rabbit Monoclonal Antibody

#3274 · $148

100
Citing papers
13.2k
Combined citations
Supplier page Find this product

Research areas

Cancer, Hypoxia, and Metabolism11Neuroscience and Neuropharmacology Research8Cancer Cells and Metastasis8Cancer-related Molecular Pathways6Epigenetics and DNA Methylation6Alzheimer's disease research and treatments5Cytokine Signaling Pathways and Interactions5Glioma Diagnosis and Treatment5

Papers citing this product

1
Modeling Alzheimer’s Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular Aβ and Differential Drug Responsiveness
Cell stem cell·2013·751 cit.·DOI
2
Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection
The Journal of Experimental Medicine·2009·454 cit.·DOI
3
IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome
The Journal of Cell Biology·2009·391 cit.·DOI
4
Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma
Stem Cells·2010·317 cit.·DOI
5
Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
Diabetes·2008·315 cit.·DOI
6
Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
Journal of Biological Chemistry·2009·312 cit.·DOI
7
Protease Inhibitors from Marine Actinobacteria as a Potential Source for Antimalarial Compound
PLoS ONE·2014·308 cit.·DOI
8
HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway
Cell Death and Differentiation·2011·308 cit.·DOI
9
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Redox Biology·2017·303 cit.·DOI
10
The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
PLoS ONE·2014·291 cit.·DOI

Similar products

ProductVendorPricePapers
G-beta-L AntibodyRabbitCell Signaling Technology$317100